Mon.Jun 03, 2024

article thumbnail

Bristol Myers' RayzeBio halts radiotherapy trial enrollment after isotope runs scarce

Fierce Pharma

Thanks to a shortage of the isotope actinium, RayzeBio has temporarily halted new patient enrollment in its phase 3 study in neuroendocrine tumors.

Patients 273
article thumbnail

Collaboration is Vital to Creating Inclusive Healthcare Technologies

MedCity News

The large-scale, multidisciplinary effort to improve the performance of pulse oximeters provides an example of the value of collaboration to solve problems and shows how industry partners can contribute in a significant way when they have a seat at the table. The post Collaboration is Vital to Creating Inclusive Healthcare Technologies appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer

Fierce Pharma

Following fellow immunotherapy regimens by Roche and AstraZeneca, Bristol Myers Squibb’s Opdivo and Yervoy want to carve out a piece of the first-line liver cancer market, too. | Following fellow immunotherapy regimens by Roche and AstraZeneca, Bristol Myers Squibb’s Opdivo and Yervoy want to carve out a piece of the first-line liver cancer market, too.

Marketing 263
article thumbnail

Technology innovation aiding process spectroscopy market growth

European Pharmaceutical Review

A report by Spherical Insights has predicted that the process spectroscopy market will value $35.8 billion by 2033. Process spectroscopy is becoming more connected to automation and digitalisation initiatives, like Industry 4.0, the report stated. The analytical technique can therefore aid smart production and predictive maintenance. Furthermore, incorporating data analytics and artificial intelligence (AI) facilitates predictive process control and optimisation, the report explained.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

ASCO: With first-in-class win, Sanofi's Sarclisa looks to step out of J&J's multiple myeloma shadow

Fierce Pharma

In the field of anti-CD38 treatment for multiple myeloma, Johnson & Johnson’s Darzalex casts a long shadow. Now, Sanofi hopes a first-in-class win will help its Sarclisa gain an edge. | In the field of anti-CD38 treatment for multiple myeloma, Johnson & Johnson’s Darzalex casts a long shadow. Now, Sanofi hopes a first-in-class win will help its Sarclisa gain an edge.

255
255
article thumbnail

The Senate Attacks on Pharma Put the Industry in Jeopardy and Consumers at Risk

MedCity News

Singling out an industry segment won’t solve the underlying problem of healthcare costs. The post The Senate Attacks on Pharma Put the Industry in Jeopardy and Consumers at Risk appeared first on MedCity News.

Pharma 105

More Trending

article thumbnail

5 Funding Announcements Made By Payer/Employer Companies In May

MedCity News

Here is a list of some of the biggest funding rounds in the payer/employer space that were announced in May. The post 5 Funding Announcements Made By Payer/Employer Companies In May appeared first on MedCity News.

102
102
article thumbnail

GSK hit with high-stakes setback in Zantac saga as judge allows tens of thousands of lawsuits to proceed

Fierce Pharma

The decision of a Delaware judge on Friday to allow more than 75,000 Zantac lawsuits to go forward to jury trials has left four major drugmakers—GSK, Pfizer, Sanofi and Boehringer Ingelheim—vulnera | The decision of a Delaware judge on Friday to allow more than 75,000 Zantac lawsuits to go forward to jury trials has left four major drugmakers—GSK, Pfizer, Sanofi and Boehringer Ingelheim—vulnerable to costly awards, settlements and litigation fees as they try to resolve claims that the heartburn

231
231
article thumbnail

ASCO: DREAMM-8 data puts GSK’s Blenrep back on track

pharmaphorum

GSK planning to refile anti-BCMA drug Blenrep in the US for multiple myeloma after reporting positive results from the DREAMM-8 trial at ASCO

109
109
article thumbnail

FDA approves Moderna’s RSV vaccine mRESVIA

Pharmaceutical Technology

Moderna has secured approval from the US Food and Drug Administration (FDA) for mRESVIA (respiratory syncytial virus vaccine).

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

ASCO: AstraZeneca’s triple whammy in lung and breast cancer

pharmaphorum

AstraZeneca's ASCO 'super sunday' delivers new data for Tagrisso and Imfinzi in lung cancer and Enhertu in breast cancer

103
103
article thumbnail

Robotics in Sterile Processing

PharmaTech

Pharmaceutical Technology® spoke with Jeff Clement, executive director of Technical Sales for Development and Manufacturing Group at PCI Pharma Services, about the challenges and benefits of incorporating robotics into aseptic manufacturing.

article thumbnail

GSK shares dive on Zantac court case ruling

pharmaphorum

Shares in GSK plummet after Delaware court says litigation claiming Zantac can cause cancer is cleared to go ahead

98
article thumbnail

Sustainability Goals Impacting Biopharma (BIO 2024)

PharmaTech

The PharmTech Group spoke with Stacey Treichler, senior director of Marketing and Strategy for Purolite at Ecolab, about the impact of advanced therapies, new innovations, and sustainability on the biopharmaceutical industry.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

To All Pediatric and Teen Mental Health Startups Seeking Investors: Apply for MedCity’s Pitch Perfect Contest!

MedCity News

The contest — which will include startup focusing on pediatric and teen behavioral health — will take place at Pegasus Park in Dallas on September 18. The deadline to submit applications is July 10, so apply today! The post To All Pediatric and Teen Mental Health Startups Seeking Investors: Apply for MedCity’s Pitch Perfect Contest! appeared first on MedCity News.

96
article thumbnail

New UCL-developed immunotherapy shows promising results in treating bone cancer

PharmaTimes

Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy

87
article thumbnail

Pharma Pulse 6/3/24: New ChatGPT Offers Lesson in AI Hype, Managing Diversity & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 105
article thumbnail

International KCL research project to develop SMARTdrugs for aggressive cancers

PharmaTimes

The platform will be used to diagnose and treat cancers, including lung and brain tumours

88
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

ASCO 2024: American Cancer Society and ASCO combine cancer resource websites

Pharmaceutical Technology

The American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) are uniting to create a single online source for credible cancer information.

59
article thumbnail

Phase III Trial Data Presented at ASCO Show Imfinzi Improves Survival in Limited-Stage Small Cell Lung Cancer

PharmExec

Results of the ADRIATIC trial indicated that treatment with Imfinzi after standard-of-care concurrent chemoradiotherapy improves overall survival and progression-free survival in patients with limited-stage small cell lung cancer.

article thumbnail

Cencora VP & Head of Cell & Gene Therapy Service Line Discusses the ThinkLive Cell and Gene Therapy Summit

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Lung-I Cheng, PhD, VP, Head of Cell & Gene Therapy Service Line, Cencora offers his thoughts on Cencora's inaugural ThinkLive Cell and Gene Therapy Summit.

Pharma 52
article thumbnail

Data Presented at ASCO Show Improved Complete Response with Jemperli as a First-Line Treatment for Locally Advanced Rectal Cancer in Patients with Mismatch Repair Deficient Status

PharmExec

Results of the Phase II AZUR-1 trial show that 100% of participants achieved a clinical complete response when treated with Jemperli for locally advanced rectal cancer in patients with mismatch repair deficient status.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Building a Culture of Excellence: How On-Demand Talent Fosters Continuous Learning

Rep-Lite

Sales team culture encompasses shared values, beliefs, behaviors, and practices that shape how sales professionals collaborate, innovate, and achieve goals. A culture of excellence prioritizes continuous learning, skill development, feedback culture, collaboration, adaptability, and a focus on customer value. Rep-Lite understands this importance and helps you hire a top-notch medical sales team to form this culture.

article thumbnail

Merck and Moderna’s cancer vaccine snags a clinical win in a field decades old

PharmaVoice

Cancer vaccines are taking off in the clinic, and a partnership between Merck and Moderna is at the forefront of a new wave of immunotherapy.

59
article thumbnail

ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?

Pharmaceutical Technology

The choice of control means that a US or European approval for Ambrx's ARX788 may not be possible based on ACE-Breast-02 study data.

article thumbnail

In an era of big patent losses, drug launches need years of runway

PharmaVoice

Jim Lang, CEO of Eversana, explains the shifting commercial environment and how past drug launch failures are informing the future.

59
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

EMA CHMP supports CStone’s sugemalimab for metastatic NSCLC

Pharmaceutical Technology

EMA's CHMP has recommended the approval of CStone's sugemalimab for the first-line treatment of metastatic non-small cell lung cancer.

52
article thumbnail

ConcertAI Announces Predictive and Generative AI Platforms for Pharma Industry at ASCO 2024

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52
article thumbnail

Lilly strikes deal with QurAlis for preclinical ALS candidate

Pharmaceutical Technology

QRL-204 is designed to restore UNC13A function, a gene identified as a risk factor in neurodegenerative diseases including ALS and dementia.

52
article thumbnail

Pharma Pulse 6/3/24: The Impact of Serialization Technology, Strategies to Help Health Plans Prepare for Risk Adjustment & more

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma 52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A